Department of Veterans Affairs Launched Psilocybin Trial
The new clinical study evaluates psilocybin as a treatment for veterans with resistant depression.
Updated on Sept. 22, 2026 in Military Jobs
Live Poll
Should participating in government-authorized clinical trials affect your security clearance eligibility?
The Department of Veterans Affairs announced the launch of the PIVOT clinical trial in August 2026. This study investigates the use of pharmaceutical-grade psilocybin for veterans suffering from treatment-resistant depression.
Why it matters
The research seeks to determine if controlled psilocybin therapy can offer relief to veterans who have not responded to conventional medical treatments for depression.
The PIVOT trial will enroll 240 veterans across 5 VA medical centers nationwide. The study operates as a controlled clinical trial despite psilocybin's classification as a Schedule I substance.
The players
Department of Veterans Affairs
This federal agency provides healthcare services and benefits to eligible military veterans.
The details
Participants receive pharmaceutical-grade psilocybin in a controlled environment paired with therapeutic support. Researchers are tracking changes in depression symptoms, PTSD severity, and patient outcomes, while also studying MDMA-assisted therapy separately.
Timeline
The Department of Veterans Affairs announced the PIVOT trial in August 2026.
Market Landscape
This trial marks a departure from traditional VA treatment protocols by exploring substances categorized under federal law as Schedule I. The initiative tests the feasibility of integrating non-traditional psychiatric therapies into the existing national healthcare infrastructure for military veterans.
Veterans participating in the trial receive supervised care, but the VA continues to warn against individual self-medication with psychedelics. Participants must weigh potential mental health benefits against the uncertain implications for their federal security clearances.
The takeaway
While the PIVOT trial explores new avenues for treating depression, the federal status of psilocybin poses unique administrative challenges for participants. Veterans are advised to consult with official VA channels regarding the clinical study rather than pursuing informal use.
Further reading
For more information on career support and benefits, visit Military Jobs.
Source note: This article includes information reported by ClearanceJobs.
Live Poll
Should participating in government-authorized clinical trials affect your security clearance eligibility?
